Effects of 5-HT4-receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 5, 1997, Pages 670-675

  Kii, Yoshihide ^a   Ito, Tsugutaka ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

5 HT4 receptor agonists; Action potential duration; Cisapride; Guinea pig papillary muscles; Mosapride citrate

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; CISAPRIDE; CLOFILIUM; MOSAPRIDE CITRATE; SEROTONIN 2 RECEPTOR; SEROTONIN 4 AGONIST; SEROTONIN RECEPTOR; ZACOPRIDE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; BENZAMIDE DERIVATIVE; FUSED HETEROCYCLIC RINGS; MORPHOLINE DERIVATIVE; MOSAPRIDE; PIPERIDINE DERIVATIVE; PRAZOSIN; QUATERNARY AMMONIUM DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG STRUCTURE; ELECTROCARDIOGRAM; GUINEA PIG; HEART MUSCLE POTENTIAL; HEART PAPILLARY MUSCLE; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; ACTION POTENTIAL; ADRENERGIC SYSTEM; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; HEART; IN VITRO STUDY; INNERVATION; MICROELECTRODE; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

ACTION POTENTIALS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; CISAPRIDE; ELECTRIC STIMULATION; ELECTROCARDIOGRAPHY; GUINEA PIGS; HEART; MALE; MICROELECTRODES; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; PAPILLARY MUSCLES; PIPERIDINES; PRAZOSIN; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, ADRENERGIC, ALPHA-2; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030612432     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199705000-00016     Document Type: Article

References (24)

1. 4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedebergs Arch Phamacol 1989;340:403-10.
2. 4 receptor. J Pharmacol Exp Ther 1990;252:1378-86.
3. 4 receptors in guinea-pig ascending colon. Eur J Pharmacol 1991;196:149-55.
4. Wiseman LR, Faulds D. Cisapride: an update review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994;47:116-52.
5. Naito Y, Kuzuhara S. Parkinsonism induced or worsened by cisapride [Abstract in English]. Jpn J Geriatr 1994;31:899-902.
6. 4 receptor dual antagonist, on colonic function in vivo. J Pharmacol Exp Ther 1993;266:74-80.
7. 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice. J Pharmacol Exp Ther 1994; 271:741-7.
8. 4 receptors mediate arrhythmias? Trends Pharmacol Sci 1994;15:451-5.
9. 4 receptor agonist in the gut. Neurogastroenterol Motil 1994;6:197-204.
10. Yoshida N, Ito T, Karasawa T, Itoh Z. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J Pharmacol Exp Ther 1991;257:781-7.
11. Miyoshi A, Miwa T, Yoshida Y, et al. Dose finding study of AS-4370 in patients with non-ulcer dyspepsia [Abstract in English]. J Clin Ther Med 1990;6:2295-310.
12. Karasawa T, Yoshida N, Furukawa K, Omoya H, Ito T. Comparison of gastrokinetic effects of AS-4370, cisapride and BRL24924. Eur J Pharmacol 1990;183:2181.
13. Bran S, Murray WA, Hirsch IB, Palmer JP. Long QT syndrome during high-dose cisapride. Arch Intern Med 1995;155:765-8.
14. Ahmad SR, Wolfe SM. Cisapride and torsades de pointes. Lancet 1995;345:508.
15. Puisieux FL, Adamantidis MM, Dumotier BM, Dupuis BA. Cisapride-induced prolongation of cardiac action potential and early afterdepolarizations in rabbit Purkinje fibres. Br J Pharmacol 1996;117:1377-9.
16. 4 receptor agonists on action potentials in guinea pig isolated papillary muscles. Jpn J Pharmacol 1996;71(suppl I):136P.
17. Sakashita M, Yamaguchi T, Miyazaki H, et al. Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects. Arzneimittelforschung 1993;43:867-72.
18. Steinberg MI, Molloy BB. Clofilium - a new antifibrillatory agent that selectively increases cellular refractoriness. Life Sci 1979;25: 1397-406.
19. Li T, Carr AA, Dage RC. Effects of MDL11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. J Cardiovasc Pharmacol 1990; 16:917-23.
20. Yoshida N, Omoya H, Kato S, Ito T. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittelforschung 1993;43:1078-83.
21. Hondeghem LM, Synders DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go: reduced effectiveness and dangers of reverse use dependence. Circulation 1990; 81:686-90.
22. + current by dofetilide. Circ Res 1993;72:75-83.
23. Grand BL, Talmant JM, Rieu JP, Patoiseau JF, Colpaert FC, John GW. Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential. J Cardiovasc Pharmacol 1995;26:803-9.
24. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 1995; 76:110-9.